Brief: KDventures: Reversed Acquisition Of SVF Vaccines By Novakand Pharma Not Completed
Feb 24 (Reuters) - Kdventures AB KDV.ST: REVERSED ACQUISITION OF SVF VACCINES NOT COMPLETED NASDAQ REJECTS APPLICATION DUE TO INSUFFICIENT OPERATIONS AND CAPITAL EVALUATING ALTERNATIVE PATHS FOR SVF VACCINES Source text: ID:nGNE1NmwFm Further company coverage: KDV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue